Stay updated on PHA-022121 Dose Study for Acute Angioedema Clinical Trial
Sign up to get notified when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.

Latest updates to the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page
- Check4 days agoChange DetectedThe study history now includes a new revision entry (v3.7.0) indicating an updated submission. The previous revision (v3.6.6) has been removed from the current history view.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe latest entry in the study's history adds Revision: v3.6.6 and removes Revision: v3.6.5, reflecting a minor update to the page's revision tracking. This indicates a small backend or metadata update on the history page.SummaryDifference0.1%

- Check47 days agoChange DetectedAdds a new revision entry (v3.6.5) to the study history and removes the previous v3.6.4 entry, reflecting an update to the revision metadata for the record.SummaryDifference0.1%

- Check61 days agoChange DetectedThe record history now shows a new revision entry, v3.6.4, replacing the previous v3.6.3 in the history. This reflects an update to the page's revision metadata for the study record.SummaryDifference0.1%

- Check83 days agoChange DetectedThe footer revision label now reads v3.6.3, replacing the previous v3.6.2.SummaryDifference0.1%

- Check90 days agoChange DetectedThe revision history now includes a new latest revision entry (v3.6.2) and drops an older one (v3.6.0), reflecting an update to the page's version tracking. This preserves the historical record without altering study details.SummaryDifference0.1%

Stay in the know with updates to PHA-022121 Dose Study for Acute Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.